Alpha 2.0
Login Register
» Authors » Anna Burelli

Anna Burelli

Explore the profile of Anna Burelli including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 39
Followers 0
Related Specialties
General Surgery
Gastroenterology
Oncology
Top 10 Co-Authors
Giovanni Marchegiani
Roberto Salvia
Giampaolo Perri
Tommaso DallOlio
Gabriele Capurso
Stefano Crippa
Claudio Bassi
Giulio Belfiori
Paolo Giorgio Arcidiacono
Laura Apadula
Published In
Ann Surg Oncol
Ann Surg
Gastroenterology
Gut
Langenbecks Arch Surg
Affiliations
Soon will be listed here.
Recent Articles
1.
Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: a competing risk analysis
Crippa S, Marchegiani G, Belfiori G, Rancoita P, Pollini T, Burelli A, et al.
Gut . 2024 Apr; 73(8):1336-1342. PMID: 38653539
Objective: Cost-effectiveness of surveillance for branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) is debated. We combined different categories of risks of IPMN progression and of IPMN-unrelated mortality to improve surveillance strategies....
2.
UEG Journal's impact and vision for the future
Elshaarawy O, Balduzzi A, Burelli A, Weerts Z
United European Gastroenterol J . 2024 Jan; 12(3):283-285. PMID: 38279697
No abstract available.
3.
Pancreatic cystic neoplasms: Still high rates of preoperative misdiagnosis in the guidelines and endoscopic ultrasound era
Salvia R, Burelli A, Nepi A, Caravati A, Tomelleri C, DallOlio T, et al.
Surgery . 2023 Sep; 174(6):1410-1415. PMID: 37758634
Background: A wrong diagnosis of nature is common in pancreatic cystic neoplasms. The aim of the current study is to reappraise the diagnostic errors for presumed pancreatic cystic neoplasms in...
4.
Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for Discontinuation
Marchegiani G, Pollini T, Burelli A, Han Y, Jung H, Kwon W, et al.
Gastroenterology . 2023 Jul; 165(4):1016-1024.e5. PMID: 37406887
Background & Aims: Currently, most patients with branch duct intraductal papillary mucinous neoplasms (BD-IPMN) are offered indefinite surveillance, resulting in health care costs with questionable benefits regarding cancer prevention. This...
5.
Correction to: More is More? Total Pancreatectomy for Periampullary Cancer as an Alternative in Patients with High-Risk Pancreatic Anastomosis: A Propensity Score-Matched Analysis
Burelli A, Perri G, Marchegiani G
Ann Surg Oncol . 2022 Apr; 29(8):5055. PMID: 35384525
No abstract available.
6.
More is More? Total Pancreatectomy for Periampullary Cancer as an Alternative in Patients with High-Risk Pancreatic Anastomosis: A Propensity Score-Matched Analysis
Burelli A, Perri G, Marchegiani G
Ann Surg Oncol . 2022 Mar; 29(6):3517-3518. PMID: 35307804
No abstract available.
7.
State-of-the-art surgical treatment of IPMNs
Salvia R, Burelli A, Perri G, Marchegiani G
Langenbecks Arch Surg . 2021 Nov; 406(8):2633-2642. PMID: 34738168
Background: A "pandemic" of incidentally discovered pancreatic cyst neoplasms (PCNs) is ongoing. Among PCNs, intraductal papillary mucinous cystic neoplasms (IPMNs) are the most common and with their complex biology could...
8.
High-risk Pancreatic Anastomosis Versus Total Pancreatectomy After Pancreatoduodenectomy: Postoperative Outcomes and Quality of Life Analysis
Marchegiani G, Perri G, Burelli A, Zoccatelli F, Andrianello S, Luchini C, et al.
Ann Surg . 2021 Apr; 276(6):e905-e913. PMID: 33914471
Objective: To evaluate TP as an alternative to PD in patients at high-risk for popf. Background: Outcomes of high-risk PD (HR-PD) and TP have never been compared. Methods: All patients...